Four Companies to Compete in the Grand Finals Hosted by MedTech Innovator Asia Pacific 7th Annual Accelerator Program in 2025

LOS ANGELES and SINGAPORE – October 16, 2025 – MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the four finalists from its 2025 Asia Pacific Accelerator cohort.

Marking its seventh year in the region, MedTech Innovator Asia Pacific continues to serve as the leading platform advancing healthcare innovation and entrepreneurship across the region. This year’s four finalists represent breakthrough technologies in neuromodulation, surgical robotics, cardiac monitoring and personalized implants, reflecting the diversity and strength of Asia Pacific’s medtech ecosystem.

The finalists, selected from 20 outstanding startups across the region, are:

  • Australis Scientific, Brisbane, Australia: Smart patch delivering minimally invasive neuromodulation therapy for overactive bladder, enabling effective treatment from clinic to home. 
  • F.MED, Fukuoka, Japan: Robotic microsurgery system enhancing precision and control in delicate procedures through fine, tremor-free handling of microscopic surgical tools. 
  • HemoTag, Boca Raton, U.S: Full-spectrum heart failure management system integrating continuous monitoring and predictive analytics for earlier intervention and improved patient outcomes. 
  • OsseoLabs, Bangkok, Thailand: Personalized implants and surgical solutions powered by 3D printing, biomechanics, and AI-advancing surgical precision, speed, and recovery outcomes. 

Each finalist will receive USD 10,000 and the opportunity to compete for USD 175,000 in non-dilutive funding at the 2025 MedTech Innovator Asia Pacific Showcase & Grand Finals, held 28 October 2025 at Geneo, Singapore.

During the Grand Finals, each of the four startups will present their transformative technologies to a distinguished panel of industry leaders. The Grand Prize winner will be selected live by audience vote.

In addition, MedTech Innovator Asia Pacific will present several other prestigious awards to recognize excellence and innovation within the 2025 cohort, including:

  • Cambridge Consultants Product Development Award (USD 25,000 in-kind)
  • Enterprise Singapore Startup SG Grant Award (SGD 50,000)
  • Best Video Competition Award (USD 5,000)

“This year’s finalists reflect the incredible breadth of medtech innovation emerging from Asia Pacific and beyond – from robotic microsurgery and personalized implants, to non-invasive detection of heart failure and neuromodulation therapies that can be delivered at home,” said Fredrik Nyberg, Managing Director, Asia Pacific, MedTech Innovator. ”They exemplify the ingenuity and clinical impact that define our region’s medtech ecosystem. We’re proud to support these visionary founders as they work to improve patient care and outcomes across the world.”

The 2025 MedTech Innovator Asia Pacific program received more than 550 applications from across the globe. Following a rigorous selection process, 60 companies were invited to pitch, and 20 were chosen to participate in the four-month accelerator program. These companies represent a wide range of innovations across medical devices, in vitro diagnostics, and digital health, gaining access to mentorship, visibility, and partnerships across the global medtech ecosystem.

MedTech Innovator’s 2025 Asia Pacific program sponsors include Johnson & Johnson MedTech, B. Braun Medical, Becton Dickinson, Siemens Healthineers, Teleflex, Cambridge Consultants, Enterprise Singapore, and The Mullings Group.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical technology companies. Its mission is to improve human health by accelerating the growth of companies that are transforming care. MedTech Innovator has been a catalyst for groundbreaking healthcare solutions, reviewing well over 14,000 applicants and fostering the growth of 838 companies globally that have collectively raised over USD 10.5 billion in follow-on funding, transforming the lives of millions. Its wholly owned subsidiary, MedTech Innovator Asia Pacific, was launched in 2019 and currently has 154 alumni companies.

For more information about MedTech Innovator Asia Pacific, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MedTech Innovator Asia Pacific’s website: www.medtechinnovator.asia, follow on LinkedIn, and subscribe to the monthly newsletter

 

# # #

Media Contact:

Bernice Tan 

Marketing & Events Manager, Asia Pacific

MedTech Innovator

bernice@medtechinnovator.org